Citations

Showing 10 of 108152 citations.

Inter- And Intra-individual Differences In Neuromuscular Responses During Submaximal Leg Extension Exercise
Dinyer, Taylor K. , Soucie, Evangeline P., Succi, Pasquale J. , Voskuil, Caleb C. , Byrd, M. Travis, Bergstrom, Haley C.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 12, 2021 | Volume: 53 | Issue: 8S | Pages: 43-43

10.1249/01.mss.0000759576.78338.64 Get It

Influence Of A Multi-ingredient Pre-workout Supplement On Energy Expenditure, Oxygen Uptake, And Subjective Feelings Of Fatigue During Low-intensity Aerobic Exercise
Stefan, Riley R., Lutsch, Daniel J., Hill, Chris , Camic, Clayton L., Jagim, Andrew R. , Hill, Chris M.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 12, 2021 | Volume: 53 | Issue: 8S | Pages: 287-288

10.1249/01.mss.0000762452.62307.d8 Get It

Sport Nutrition Knowledge And Perceptions Of Dietary Requirements Among A Diverse Cohort Of Collegiate Athletes.
Luedke, Joel, Erickson, Jacob L. , Jagim, Andrew R. , Kerksick, Chad M.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 12, 2021 | Volume: 53 | Issue: 8S | Pages: 273-274

10.1249/01.mss.0000762268.93478.76 Get It

Signal quality and power spectrum analysis of remote ultra long‐term subcutaneous EEG
Viana, Pedro F. , Remvig, Line Sofie, Duun‐Henriksen, Jonas , Glasstetter, Martin , Dümpelmann, Matthias , Nurse, Ewan S. , Martins, Isabel Pavão , Schulze‐Bonhage, Andreas , Brinkmann, Benjamin H. , Richardson, Mark P. , Brinkmann, Benjamin H , Kjaer, Troels W , Nurse, Ewan , Schulze-Bonhage, Andreas , Dümpelmann, Matthias , Richardson, Mark P , Duun-Henriksen, Jonas , Pavão Martins, Isabel , Viana, Pedro F , Freestone, Dean R.

Mayo Clinic

Epilepsia | July 12, 2021 | Volume: 62 | Issue: 8 | Pages: 1820-1828

10.1111/epi.16969 | PMID 34250608 Get It

Abstract Objective Ultra long‐term subcutaneous electroencephalography (sqEEG) monitoring is a new modality with great potential for both health and disease, including epileptic seizure detection and forecasting. However, little is known about the long‐term quality and consistency of the sqEEG signal, which is the objective of this study. Methods The largest multicenter cohort of sqEEG was analyzed, including 14 patients with epilepsy and 12 healthy subjects, implanted with a sqEEG device (24/7 EEG ™ SubQ), and recorded from 23 to 230 days (median 42 days), with a median data capture rate of 75% (17.9 hours/day). Median power spectral density plots of each subject were examined for physiological peaks, including at diurnal and nocturnal periods. Long‐term temporal trends in signal impedance and power spectral features were investigated with subject‐specific linear regression models and group‐level linear mixed‐effects models. Results sqEEG spectrograms showed an approximate 1/f power distribution. Diurnal peaks in the alpha range (8‐13Hz) and nocturnal peaks in the sigma range (12‐16Hz) were seen in the majority of subjects. Signal impedances remained low, and frequency band powers were highly stable throughout the recording periods. Significance The spectral characteristics of minimally invasive, ultra long‐term sqEEG are similar to scalp EEG, whereas the signal is highly stationary. Our findings reinforce the suitability of this system for chronic implantation on diverse clinical applications, from seizure detection and forecasting to brain‐computer interfaces.
Outcomes of adult patients supported by extracorporeal membrane oxygenation (ECMO) following cardiopulmonary arrest. The Mayo Clinic experience
Guru, Pramod , Seelhammer, Troy G. , Singh, Tarun D. , Sanghavi, Devang , Chaudhary, Sanjay , Riley, Jeffrey B., Friedrich, Tammy, Stulak, John M., Haile, Dawit T. , Schears, Gregory J. , Guru, Pramod K , Sanghavi, Devang K., Chaudhary, Sanjay , Kashyap, Rahul

Mayo Clinic

Journal of Cardiac Surgery | July 12, 2021 | Volume: 36 | Issue: 10 | Pages: 3528-3539

10.1111/jocs.15804 | PMID 34250642 Get It

Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
Kim, Kyung‐Hee , Pereira, Naveen L. , Kim, Kyung-Hee

Mayo Clinic

Korean Circulation Journal | July 12, 2021 | Volume: 51 | Issue: 10 | Pages: 797

10.4070/kcj.2021.0154 | PMID 34327881 Get It

Outcomes of Kidney Transplant Recipients with Sickle Cell Disease: An Analysis of the 2000–2019 UNOS/OPTN Database
Leeaphorn, Napat , Vaitla, Pradeep , Hansrivijit, Panupong , Jadlowiec, Caroline C. , Chewcharat, Api , Katari, Sreelatha , Pattharanitima, Pattharawin , Kaewput, Wisit , Mao, Michael A. , Cooper, Matthew , Cheungpasitporn, Wisit , Vaitla, Pradeep K , Hansrivijit, Panupong , Jadlowiec, Caroline , Mao, Shennen A. , Chewcharat, Api , Pattharanitima, Pattharawin , Mao, Michael A , Cooper, Matthew , Cheungpasitporn, Wisit , Kaewput, Wisit , Thongprayoon, Charat , Boonpheng, Boonphiphop

Mayo Clinic

Journal of Clinical Medicine | July 12, 2021 | Volume: 10 | Issue: 14 | Pages: 3063

10.3390/jcm10143063 | PMID 34300230 Get It

Background: Lower patient survival has been observed in sickle cell disease (SCD) patients who go on to receive a kidney transplant. This study aimed to assess the post-transplant outcomes of SCD kidney transplant recipients in the contemporary era. Methods: We used the OPTN/UNOS database to identify first-time kidney transplant recipients from 2010 through 2019. We compared patient and allograft survival between recipients with SCD (n = 105) vs. all other diagnoses (non-SCD, n = 146,325) as the reported cause of end-stage kidney disease. We examined whether post-transplant outcomes improved among SCD in the recent era (2010–2019), compared to the early era (2000–2009). Results: After adjusting for differences in baseline characteristics, SCD was significantly associated with lower patient survival (HR 2.87; 95% CI 1.75–4.68) and death-censored graft survival (HR 1.98; 95% CI 1.30–3.01), compared to non-SCD recipients. The lower patient survival and death-censored graft survival in SCD recipients were consistently observed in comparison to outcomes of recipients with diabetes, glomerular disease, and hypertension as the cause of end-stage kidney disease. There was no significant difference in death censored graft survival (HR 0.99; 95% CI 0.51–1.73, p = 0.98) and patient survival (HR 0.93; 95% CI 0.50–1.74, p = 0.82) of SCD recipients in the recent versus early era. Conclusions: Patient and allograft survival in SCD kidney recipients were worse than recipients with other diagnoses. Overall SCD patient and allograft outcomes in the recent era did not improve from the early era. The findings of our study should not discourage kidney transplantation for ESKD patients with SCD due to a known survival benefit of transplantation compared with remaining on dialysis. Urgent future studies are needed to identify strategies to improve patient and allograft survival in SCD kidney recipients. In addition, it may be reasonable to assign risk adjustment for SCD patients.
Obstetric outcomes after fetal intervention – a single-center descriptive review
Narang, Kavita , Ibirogba, Eniola R. , Sangi‐Haghpeykar, Haleh , Ruano, Rodrigo , Ruano, Rodrigo , Ibirogba, Eniola R

Mayo Clinic

The Journal of Maternal-Fetal & Neonatal Medicine | July 11, 2021 | Volume: 35 | Issue: 25 | Pages: 7102-7108

10.1080/14767058.2021.1943658 | PMID 36411675 Get It

Alcohol‐associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics
Singal, Ashwani K. , Arsalan, Arshad, Arab, Juan Pablo , Wong, Robert J. , Kuo, Yong‐Fang , Kamath, Patrick S. , Shah, Vijay H. , Arab, Juan P , Wong, Robert J , Singal, Ashwani K , Dunn, Winston

Mayo Clinic

Alimentary Pharmacology & Therapeutics | July 11, 2021 | Volume: 54 | Issue: 4 | Pages: 451-461

10.1111/apt.16461 | PMID 34247424 Get It

SummaryBackgroundAlcohol use and alcohol‐associated liver disease (ALD) burden are increasing in young individuals.AimTo assess host factors associated with this burden.MethodsNational Health and Nutrition Examination Survey (NHANES), National Inpatient Sample (NIS), and United Network for Organ Sharing (UNOS) databases (2006‐2016) were used to identify individuals with harmful alcohol use, ALD‐related admissions, and ALD‐related LT listings respectively.ResultsOf 15 981 subjects in NHANES database, weighted prevalence of harmful alcohol use was 17.7%, 29.3% in <35 years (G1) versus 16.9% in 35‐64 years (G2) versus 5.1% in ≥65 years (G3). Alcohol use was about 11 and 4.7 folds higher in G1 and G2 versus G3, respectively. Male gender and Hispanic race associated with harmful alcohol use. Of 593 600 ALD admissions (5%, 77%, and 18% in G1‐G3 respectively), acute on chronic liver failure (ACLF) occurred in 7.2%, (7.2 in G2 vs 6.7% in G1 and G3, P < 0.001). After controlling for other variables, ACLF development among ALD hospitalizations was higher by 14% and 10% in G1 and G2 versus G3, respectively. Female gender and Hispanic race were associated with increased ACLF risk by 8% and 17% respectively. Of 20,245 ALD LT listings (3.4%, 84.4%, and 12.2% in G1‐G3 respectively), ACLF occurred in 28% candidates. Risk of severe (grade 2 or 3) ACLF was higher by about 1.7 fold in G1, 1.5 fold in females and 20% in Hispanics.ConclusionYoung age, female gender, and Hispanic race are independently associated with ALD‐related burden and ACLF in the United States. If these findings are validated in prospective studies, strategies will be needed to reduce alcohol use in high risk individuals to reduce burden from ALD.
Activation Pattern During His-Bundle Pacing
Yasin, Omar , Bush, Jaime, Vaidya, Vaibhav R. , Tri, Jason , Zyl, Martin van , Xiao, Peilin , Scheuermann, Cory, Asirvatham, Samuel J. , Cha, Yong‐Mei , Asirvatham, Samuel J , Xiao, Peilin , Han, Jie

Mayo Clinic

No container title available | July 11, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.162602806.64990926/v1 Get It